PL3668853T3 - Nowe związki - Google Patents

Nowe związki

Info

Publication number
PL3668853T3
PL3668853T3 PL18752172T PL18752172T PL3668853T3 PL 3668853 T3 PL3668853 T3 PL 3668853T3 PL 18752172 T PL18752172 T PL 18752172T PL 18752172 T PL18752172 T PL 18752172T PL 3668853 T3 PL3668853 T3 PL 3668853T3
Authority
PL
Poland
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
PL18752172T
Other languages
English (en)
Inventor
Esther Porras De Francisco
Modesto Jesús REMUIÑAN-BLANCO
Marilyne BOUROTTE
Benoit Deprez
Nicolas Willand
Original Assignee
Glaxosmithkline Intellectual Property Development Limited
BioVersys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Intellectual Property Development Limited, BioVersys AG filed Critical Glaxosmithkline Intellectual Property Development Limited
Publication of PL3668853T3 publication Critical patent/PL3668853T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL18752172T 2017-08-16 2018-08-15 Nowe związki PL3668853T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382570 2017-08-16
PCT/EP2018/072144 WO2019034701A1 (en) 2017-08-16 2018-08-15 NEW COMPOUNDS
EP18752172.9A EP3668853B1 (en) 2017-08-16 2018-08-15 Novel compounds

Publications (1)

Publication Number Publication Date
PL3668853T3 true PL3668853T3 (pl) 2022-01-31

Family

ID=59713958

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18752172T PL3668853T3 (pl) 2017-08-16 2018-08-15 Nowe związki

Country Status (21)

Country Link
US (2) US11969423B2 (pl)
EP (1) EP3668853B1 (pl)
JP (1) JP7183270B2 (pl)
KR (1) KR102657861B1 (pl)
CN (1) CN111225910B (pl)
AU (1) AU2018317805B2 (pl)
CA (1) CA3072839A1 (pl)
CY (1) CY1124865T1 (pl)
DK (1) DK3668853T3 (pl)
ES (1) ES2902600T3 (pl)
HR (1) HRP20211894T1 (pl)
HU (1) HUE057050T2 (pl)
LT (1) LT3668853T (pl)
PL (1) PL3668853T3 (pl)
PT (1) PT3668853T (pl)
RS (1) RS62718B1 (pl)
RU (1) RU2767652C2 (pl)
SI (1) SI3668853T1 (pl)
SM (1) SMT202100726T1 (pl)
WO (1) WO2019034701A1 (pl)
ZA (1) ZA202000586B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026073180A2 (en) * 2024-09-30 2026-04-02 Revolution Medicines, Inc. Synthesis of ras inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10250080A1 (de) 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
FR2903405B1 (fr) * 2006-07-04 2011-09-09 Pasteur Institut Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
PT2439205E (pt) * 2006-12-29 2015-07-16 Abbvie Deutschland Compostos de carboxamida e seus usos como inibidores de calpaína
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
EP2771338A2 (en) * 2011-10-25 2014-09-03 Université de Droit et de la Santé de Lille 2 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes

Also Published As

Publication number Publication date
CN111225910B (zh) 2023-03-24
KR20200041345A (ko) 2020-04-21
EP3668853B1 (en) 2021-09-29
US11969423B2 (en) 2024-04-30
RU2020109672A (ru) 2021-09-16
JP2020531576A (ja) 2020-11-05
CA3072839A1 (en) 2019-02-21
PT3668853T (pt) 2021-12-02
HRP20211894T1 (hr) 2022-08-19
SI3668853T1 (sl) 2022-02-28
US20200253967A1 (en) 2020-08-13
LT3668853T (lt) 2022-03-10
CY1124865T1 (el) 2022-11-25
DK3668853T3 (da) 2021-12-06
AU2018317805B2 (en) 2021-04-15
RS62718B1 (sr) 2022-01-31
WO2019034701A1 (en) 2019-02-21
US20240307385A1 (en) 2024-09-19
CN111225910A (zh) 2020-06-02
SMT202100726T1 (it) 2022-01-10
KR102657861B1 (ko) 2024-04-17
ES2902600T3 (es) 2022-03-29
BR112020003221A2 (pt) 2020-10-06
EP3668853A1 (en) 2020-06-24
AU2018317805A1 (en) 2020-02-20
JP7183270B2 (ja) 2022-12-05
RU2767652C2 (ru) 2022-03-18
RU2020109672A3 (pl) 2021-10-18
ZA202000586B (en) 2021-08-25
HUE057050T2 (hu) 2022-04-28

Similar Documents

Publication Publication Date Title
GB201700814D0 (en) Compounds
IL272562A (en) new compounds
GB201720187D0 (en) Novel Compounds
GB201702947D0 (en) Novel compounds
ZA202000586B (en) Novel compounds
GB201721736D0 (en) Novel Compounds
GB201721735D0 (en) Novel Compounds
GB201721726D0 (en) Novel compounds
GB201721731D0 (en) Novel compounds
GB201721732D0 (en) Novel Compounds
GB201721727D0 (en) Novel compounds
GB201721729D0 (en) Novel compounds
GB201719720D0 (en) Novel compounds
GB201718564D0 (en) Novel compounds
GB201718563D0 (en) Novel compounds
GB201718561D0 (en) Novel compounds
GB201718565D0 (en) Novel compounds
GB201716131D0 (en) Novel compounds
GB201714699D0 (en) Novel compounds
GB201713082D0 (en) Novel compounds
GB201713079D0 (en) Novel Compounds
GB201713076D0 (en) Novel compounds
GB201713083D0 (en) Novel compounds
GB201713085D0 (en) Novel compounds
GB201711682D0 (en) Novel compounds